Insider Trades80 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 11, 2026 | Sell | MIRM | Eric Bjerkholt | CHIEF FINANCIAL OFFICER | 6,001 | $99.90 | $6.4B | -24.45% | +55.33% | $599.5K | -14.17% | 10b5-1 | Stalk |
| Aug 10, 2026 | Sell | MIRM | Christopher Peetz | CHIEF EXECUTIVE OFFICER | 40,000 | $50.93 | $6.4B | -24.45% | +55.33% | $2.0M | +0.00% | 10b5-1 | Stalk |
| Aug 3, 2026 | Sell | MIRM | Jolanda Howe | SVP, GLOBAL CONTROLLER | 1,840 | $105.29 | $6.4B | -24.45% | +55.33% | $193.7K | -59.09% | 10b5-1 | Stalk |
| Jul 6, 2026 | Sell | MIRM | Eric Bjerkholt | CHIEF FINANCIAL OFFICER | 5,000 | $122.25 | $6.4B | -24.45% | +55.33% | $611.3K | -2.83% | 10b5-1 | Stalk |
| Jul 6, 2026 | Sell | MIRM | Christopher Peetz | CHIEF EXECUTIVE OFFICER | 40,000 | $62.60 | $6.4B | -24.45% | +55.33% | $2.5M | +0.00% | 10b5-1 | Stalk |
| Jul 1, 2026 | Sell | MIRM | Jolanda Howe | SVP, GLOBAL CONTROLLER | 2,721 | $120.00 | $6.4B | -24.45% | +55.33% | $326.5K | -46.63% | 10b5-1 | Stalk |
| Jun 17, 2026 | Sell | MIRM | Jolanda Howe | SVP, GLOBAL CONTROLLER | 2,594 | $101.95 | $6.4B | -24.45% | +55.33% | $264.5K | -30.77% | 10b5-1 | Stalk |
| Jun 8, 2026 | Sell | MIRM | Eric Bjerkholt | CHIEF FINANCIAL OFFICER | 7,393 | $72.02 | $6.4B | -24.45% | +55.33% | $532.5K | -1.21% | 10b5-1 | Stalk |
| Jun 5, 2026 | Buy | MIRM | Peter Radovich | PRESIDENT AND COO | 16,988 | $19.19 | $6.4B | -24.45% | +55.33% | $326.0K | +19.24% | — | Stalk |
| Jun 1, 2026 | Sell | MIRM | Christopher Peetz | CHIEF EXECUTIVE OFFICER | 60,000 | $49.39 | $6.4B | -24.45% | +55.33% | $3.0M | +0.00% | 10b5-1 | Stalk |
| Mar 16, 2026 | Sell | MIRM | Jolanda Howe | SVP, GLOBAL CONTROLLER | 4,732 | $91.98 | $6.4B | -24.45% | +55.33% | $435.2K | -29.28% | — | Stalk |
| Mar 16, 2026 | Sell | MIRM | Joanne Quan | CHIEF MEDICAL OFFICER | 7,287 | $91.98 | $6.4B | -24.45% | +55.33% | $670.2K | -22.20% | — | Stalk |
| Mar 16, 2026 | Sell | MIRM | Eric Bjerkholt | CHIEF FINANCIAL OFFICER | 7,287 | $91.98 | $6.4B | -24.45% | +55.33% | $670.2K | -11.43% | — | Stalk |
| Mar 16, 2026 | Sell | MIRM | Peter Radovich | PRESIDENT AND COO | 16,515 | $91.98 | $6.4B | -24.45% | +55.33% | $1.5M | -24.18% | — | Stalk |
| Mar 16, 2026 | Sell | MIRM | Christopher Peetz | CHIEF EXECUTIVE OFFICER | 40,985 | $91.98 | $6.4B | -24.45% | +55.33% | $3.8M | -15.75% | — | Stalk |
| Mar 6, 2026 | Buy | MIRM | Peter Radovich | PRESIDENT AND COO | 5,912 | $15.87 | $6.4B | -24.45% | +55.33% | $93.8K | +7.91% | — | Stalk |
| Feb 2, 2026 | Sell | MIRM | Jolanda Howe | SVP, GLOBAL CONTROLLER | 968 | $103.30 | $6.4B | -24.45% | +55.33% | $100.0K | -17.69% | — | Stalk |
| Feb 2, 2026 | Sell | MIRM | Peter Radovich | PRESIDENT AND COO | 2,631 | $103.30 | $6.4B | -24.45% | +55.33% | $271.8K | -11.30% | — | Stalk |
| Feb 2, 2026 | Sell | MIRM | Christopher Peetz | CHIEF EXECUTIVE OFFICER | 9,108 | $103.30 | $6.4B | -24.45% | +55.33% | $940.9K | -5.38% | — | Stalk |
| Jan 26, 2026 | Sell | MIRM | Jolanda Howe | SVP, GLOBAL CONTROLLER | 842 | $96.19 | $6.4B | -24.45% | +55.33% | $81.0K | -13.94% | — | Stalk |
| Jan 26, 2026 | Sell | MIRM | Eric Bjerkholt | CHIEF FINANCIAL OFFICER | 1,053 | $96.19 | $6.4B | -24.45% | +55.33% | $101.3K | -2.22% | — | Stalk |
| Jan 26, 2026 | Sell | MIRM | Peter Radovich | PRESIDENT AND COO | 3,143 | $96.19 | $6.4B | -24.45% | +55.33% | $302.3K | -9.77% | — | Stalk |
| Jan 26, 2026 | Sell | MIRM | Christopher Peetz | CHIEF EXECUTIVE OFFICER | 6,831 | $96.19 | $6.4B | -24.45% | +55.33% | $657.1K | -3.62% | — | Stalk |
| Jan 22, 2026 | Sell | MIRM | Jolanda Howe | SVP, GLOBAL CONTROLLER | 926 | $93.33 | $6.4B | -24.45% | +55.33% | $86.4K | -13.13% | — | Stalk |
| Jan 22, 2026 | Sell | MIRM | Eric Bjerkholt | CHIEF FINANCIAL OFFICER | 1,421 | $93.33 | $6.4B | -24.45% | +55.33% | $132.6K | -2.83% | — | Stalk |
| Jan 22, 2026 | Sell | MIRM | Joanne Quan | CHIEF MEDICAL OFFICER | 1,822 | $93.33 | $6.4B | -24.45% | +55.33% | $170.0K | -8.55% | — | Stalk |
| Jan 22, 2026 | Sell | MIRM | Peter Radovich | PRESIDENT AND COO | 2,382 | $93.33 | $6.4B | -24.45% | +55.33% | $222.3K | -7.59% | — | Stalk |
| Jan 22, 2026 | Sell | MIRM | Christopher Peetz | CHIEF EXECUTIVE OFFICER | 7,098 | $93.33 | $6.4B | -24.45% | +55.33% | $662.4K | -3.61% | — | Stalk |
| Jan 20, 2026 | Sell | MIRM | Joanne Quan | CHIEF MEDICAL OFFICER | 6,911 | $90.27 | $6.4B | -24.45% | +55.33% | $623.9K | -22.50% | — | Stalk |
| Dec 31, 2025 | Sell | MIRM | Christopher Peetz | CHIEF EXECUTIVE OFFICER | 21,070 | $78.99 | $6.4B | -24.45% | +55.33% | $1.7M | -10.10% | — | Stalk |
| Nov 18, 2025 | Buy | MIRM | Christopher Peetz | CHIEF EXECUTIVE OFFICER | 19,133 | $19.24 | $6.4B | -24.45% | +55.33% | $368.1K | +6.60% | — | Stalk |
| Sep 12, 2025 | Sell | MIRM | Eric Bjerkholt | CHIEF FINANCIAL OFFICER | 9,578 | $76.01 | $6.4B | -24.45% | +55.33% | $728.0K | -14.12% | — | Stalk |
| Aug 12, 2025 | Buy | MIRM | Eric Bjerkholt | CHIEF FINANCIAL OFFICER | 2,954 | $26.49 | $6.4B | -24.45% | +55.33% | $78.3K | +5.16% | — | Stalk |
| Aug 11, 2025 | Sell | MIRM | Christopher Peetz | CHIEF EXECUTIVE OFFICER | 80,000 | $32.47 | $6.4B | -24.45% | +55.33% | $2.6M | +0.00% | 10b5-1 | Stalk |
| Aug 7, 2025 | Sell | MIRM | Jolanda Howe | SVP, GLOBAL CONTROLLER | 20,000 | $32.13 | $6.4B | -24.45% | +55.33% | $642.7K | +0.00% | 10b5-1 | Stalk |
| Aug 7, 2025 | Sell | MIRM | Christopher Peetz | CHIEF EXECUTIVE OFFICER | 80,000 | $29.09 | $6.4B | -24.45% | +55.33% | $2.3M | +0.00% | 10b5-1 | Stalk |
| Jul 2, 2025 | Sell | MIRM | Jolanda Howe | SVP, GLOBAL CONTROLLER | 1,041 | $48.63 | $6.4B | -24.45% | +55.33% | $50.6K | -16.34% | 10b5-1 | Stalk |
| Mar 18, 2025 | Sell | MIRM | Jolanda Howe | SVP, GLOBAL CONTROLLER | 2,415 | $44.45 | $6.4B | -24.45% | +55.33% | $107.3K | -49.89% | 10b5-1 | Stalk |
| Mar 17, 2025 | Sell | MIRM | Peter Radovich | PRESIDENT AND COO | 7,879 | $44.21 | $6.4B | -24.45% | +55.33% | $348.4K | -23.33% | — | Stalk |
| Mar 17, 2025 | Sell | MIRM | Christopher Peetz | CHIEF EXECUTIVE OFFICER | 27,279 | $44.21 | $6.4B | -24.45% | +55.33% | $1.2M | -14.29% | — | Stalk |
| Mar 17, 2025 | Sell | MIRM | Jolanda Howe | SVP, GLOBAL CONTROLLER | 110,506 | $24.53 | $6.4B | -24.45% | +55.33% | $2.7M | -4.98% | 10b5-1 | Stalk |
| Mar 4, 2025 | Sell | MIRM | Peter Radovich | PRESIDENT AND COO | 14,850 | $45.58 | $6.4B | -24.45% | +55.33% | $676.9K | -36.90% | — | Stalk |
| Mar 3, 2025 | Sell | MIRM | Christopher Peetz | CHIEF EXECUTIVE OFFICER | 80,000 | $24.92 | $6.4B | -24.45% | +55.33% | $2.0M | +0.00% | 10b5-1 | Stalk |
| Feb 3, 2025 | Sell | MIRM | Jolanda Howe | SVP, GLOBAL CONTROLLER | 1,064 | $48.22 | $6.4B | -24.45% | +55.33% | $51.3K | -15.06% | — | Stalk |
| Feb 3, 2025 | Sell | MIRM | Peter Radovich | PRESIDENT AND COO | 2,627 | $48.22 | $6.4B | -24.45% | +55.33% | $126.7K | -8.88% | — | Stalk |
| Feb 3, 2025 | Sell | MIRM | Christopher Peetz | CHIEF EXECUTIVE OFFICER | 9,102 | $48.22 | $6.4B | -24.45% | +55.33% | $438.9K | -7.28% | — | Stalk |
| Jan 24, 2025 | Sell | MIRM | Jolanda Howe | SVP, GLOBAL CONTROLLER | 902 | $47.92 | $6.4B | -24.45% | +55.33% | $43.2K | -12.15% | — | Stalk |
| Jan 24, 2025 | Sell | MIRM | Peter Radovich | PRESIDENT AND COO | 3,177 | $47.92 | $6.4B | -24.45% | +55.33% | $152.3K | -7.18% | — | Stalk |
| Jan 24, 2025 | Sell | MIRM | Christopher Peetz | CHIEF EXECUTIVE OFFICER | 6,837 | $47.92 | $6.4B | -24.45% | +55.33% | $327.7K | -4.36% | — | Stalk |
| Jan 17, 2025 | Sell | MIRM | Joanne Quan | CHIEF MEDICAL OFFICER | 6,969 | $45.86 | $6.4B | -24.45% | +55.33% | $319.6K | -18.53% | — | Stalk |
| Jan 7, 2025 | Sell | MIRM | Jolanda Howe | SVP, GLOBAL CONTROLLER | 750 | $42.82 | $6.4B | -24.45% | +55.33% | $32.1K | -20.40% | — | Stalk |
| Jan 7, 2025 | Sell | MIRM | Peter Radovich | PRESIDENT AND COO | 1,998 | $42.82 | $6.4B | -24.45% | +55.33% | $85.5K | -6.89% | — | Stalk |
| Jan 7, 2025 | Sell | MIRM | Christopher Peetz | CHIEF EXECUTIVE OFFICER | 7,489 | $42.82 | $6.4B | -24.45% | +55.33% | $320.6K | -5.90% | — | Stalk |
| Nov 14, 2024 | Sell | MIRM | Jolanda Howe | SVP, GLOBAL CONTROLLER | 5,000 | $25.02 | $6.4B | -24.45% | +55.33% | $125.1K | +0.00% | — | Stalk |
| Nov 8, 2024 | Buy | MIRM | Christopher Peetz | CHIEF EXECUTIVE OFFICER | 65 | $21.05 | $6.4B | -24.45% | +55.33% | $1.4K | +0.05% | — | Stalk |
| Nov 8, 2024 | Buy | MIRM | Joanne Quan | CHIEF MEDICAL OFFICER | 118 | $21.05 | $6.4B | -24.45% | +55.33% | $2.5K | — | — | Stalk |
| Nov 8, 2024 | Buy | MIRM | Eric Bjerkholt | CHIEF FINANCIAL OFFICER | 475 | $21.05 | $6.4B | -24.45% | +55.33% | $10.0K | +1.45% | — | Stalk |
| Jul 23, 2024 | Buy | MIRM | Christopher Peetz | CHIEF EXECUTIVE OFFICER | 34,013 | $2.94 | $6.4B | -24.45% | +55.33% | $99.9K | +9.16% | — | Stalk |
| Jul 2, 2024 | Sell | MIRM | Jolanda Howe | SVP, GLOBAL CONTROLLER | 375 | $34.00 | $6.4B | -24.45% | +55.33% | $12.8K | -9.76% | — | Stalk |
| Jun 24, 2024 | Sell | MIRM | Pamela Vig | CHIEF SCIENTIFIC OFFICER | 61,118 | $18.47 | $6.4B | -24.45% | +55.33% | $1.1M | +0.00% | 10b5-1 | Stalk |
| May 10, 2024 | Buy | MIRM | Pamela Vig | CHIEF SCIENTIFIC OFFICER | 94 | $21.05 | $6.4B | -24.45% | +55.33% | $2.0K | +0.34% | — | Stalk |
| May 10, 2024 | Buy | MIRM | Eric Bjerkholt | CHIEF FINANCIAL OFFICER | 470 | $21.05 | $6.4B | -24.45% | +55.33% | $9.9K | +3.36% | — | Stalk |
| May 10, 2024 | Buy | MIRM | Christopher Peetz | CHIEF EXECUTIVE OFFICER | 817 | $21.05 | $6.4B | -24.45% | +55.33% | $17.2K | +0.89% | — | Stalk |
| Mar 27, 2024 | Buy | MIRM | Eric Bjerkholt | CHIEF FINANCIAL OFFICER | 2,000 | $24.80 | $6.4B | -24.45% | +55.33% | $49.6K | +16.67% | — | Stalk |
| Mar 25, 2024 | Sell | MIRM | Peter Radovich | PRESIDENT AND COO | 4,303 | $25.80 | $6.4B | -24.45% | +55.33% | $111.0K | -12.92% | — | Stalk |
| Mar 18, 2024 | Buy | MIRM | Eric Bjerkholt | CHIEF FINANCIAL OFFICER | 2,000 | $25.80 | $6.4B | -24.45% | +55.33% | $51.6K | +20.00% | — | Stalk |
| Feb 2, 2024 | Sell | MIRM | Jolanda Howe | SVP, GLOBAL CONTROLLER | 735 | $26.19 | $6.4B | -24.45% | +55.33% | $19.3K | -12.17% | — | Stalk |
| Feb 2, 2024 | Sell | MIRM | Lara Longpre | CHIEF DEVELOPMENT OFFICER | 847 | $26.19 | $6.4B | -24.45% | +55.33% | $22.2K | -0.80% | — | Stalk |
| Feb 2, 2024 | Sell | MIRM | Pamela Vig | CHIEF SCIENTIFIC OFFICER | 1,214 | $26.19 | $6.4B | -24.45% | +55.33% | $31.8K | -4.06% | — | Stalk |
| Feb 2, 2024 | Sell | MIRM | Peter Radovich | PRESIDENT AND COO | 1,790 | $26.19 | $6.4B | -24.45% | +55.33% | $46.9K | -4.91% | — | Stalk |
| Feb 2, 2024 | Sell | MIRM | Christopher Peetz | CHIEF EXECUTIVE OFFICER | 6,013 | $26.19 | $6.4B | -24.45% | +55.33% | $157.5K | -5.46% | — | Stalk |
| Jan 8, 2024 | Sell | MIRM | Jolanda Howe | SVP, GLOBAL CONTROLLER | 528 | $28.04 | $6.4B | -24.45% | +55.33% | $14.8K | -21.12% | — | Stalk |
| Jan 8, 2024 | Sell | MIRM | Lara Longpre | CHIEF DEVELOPMENT OFFICER | 1,019 | $28.04 | $6.4B | -24.45% | +55.33% | $28.6K | -0.96% | — | Stalk |
| Jan 8, 2024 | Sell | MIRM | Pamela Vig | HEAD OF RESEARCH & DEVELOPMENT | 1,408 | $28.03 | $6.4B | -24.45% | +55.33% | $39.5K | -4.50% | — | Stalk |
| Jan 8, 2024 | Sell | MIRM | Peter Radovich | CHIEF OPERATING OFFICER | 1,408 | $28.03 | $6.4B | -24.45% | +55.33% | $39.5K | -3.72% | — | Stalk |
| Jan 8, 2024 | Sell | MIRM | Christopher Peetz | PRESIDENT AND CEO | 5,209 | $28.03 | $6.4B | -24.45% | +55.33% | $146.0K | -4.52% | — | Stalk |
| Dec 5, 2023 | Sell | MIRM | Jolanda Howe | SVP, Global Controller | 5,000 | $17.67 | $6.4B | -24.45% | +55.33% | $88.3K | +0.00% | — | Stalk |
| Nov 10, 2023 | Buy | MIRM | Peter Radovich | Chief Operating Officer | 218 | $22.29 | $6.4B | -24.45% | +55.33% | $4.9K | +0.58% | — | Stalk |
| Nov 10, 2023 | Buy | MIRM | Lara Longpre | Chief Development Officer | 434 | $22.29 | $6.4B | -24.45% | +55.33% | $9.7K | +0.41% | — | Stalk |
| Nov 10, 2023 | Buy | MIRM | Pamela Vig | Head of Research & Development | 527 | $22.29 | $6.4B | -24.45% | +55.33% | $11.7K | +1.71% | — | Stalk |